1. Home
  2. EPRT vs ORKA Comparison

EPRT vs ORKA Comparison

Compare EPRT & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

HOLD

Current Price

$30.03

Market Cap

6.9B

Sector

Real Estate

ML Signal

HOLD

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$91.72

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPRT
ORKA
Founded
2016
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
7.1B
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
EPRT
ORKA
Price
$30.03
$91.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
12
Target Price
$36.79
$92.50
AVG Volume (30 Days)
1.1M
761.4K
Earning Date
04-22-2026
05-13-2026
Dividend Yield
3.98%
N/A
EPS Growth
11.30
N/A
EPS
0.62
N/A
Revenue
$561,219,000.00
N/A
Revenue This Year
$17.12
N/A
Revenue Next Year
$16.27
N/A
P/E Ratio
$48.39
N/A
Revenue Growth
24.82
N/A
52 Week Low
$28.95
$14.67
52 Week High
$34.73
$115.52

Technical Indicators

Market Signals
Indicator
EPRT
ORKA
Relative Strength Index (RSI) 36.90 40.35
Support Level $29.31 $82.34
Resistance Level $31.49 $95.02
Average True Range (ATR) 0.40 5.35
MACD -0.08 -2.60
Stochastic Oscillator 6.57 20.19

Price Performance

Historical Comparison
EPRT
ORKA

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Share on Social Networks: